Conflict of interest among Italian medical oncologists: a national survey.

Andrea DeCensi,Gianmauro Numico,Enzo Ballatori,Fabrizio Artioli,Mario Clerico,Luisa Fioretto, Virginia Livellara, Benedetta Ruggeri, Maurizio Tomirotti,Claudio Verusio,Fausto Roila, Italian College of Chief Medical Oncologists (CIPOMO)

BMJ open(2018)

引用 4|浏览18
暂无评分
摘要
OBJECTIVES:To assess Italian medical oncologists' opinion on the implications of conflict of interest (COI) on medical education, care and research, and to evaluate their direct financial relationships. DESIGN:National cross-sectional survey conducted between March and April 2017 among Italian oncologists. SETTING:Online survey sponsored by the Italian College of Medical Oncology Chiefs through its website. PARTICIPANTS:Italian oncologists who filled out an anonymous questionnaire including 19 items and individual and working characteristics. MAIN OUTCOME MEASURE:The proportion of medical oncologists perceiving COI as an outstanding issue and those receiving direct payments from industry. RESULTS:There were 321 respondents, representing 13% of Italian tenured medical oncologists. Overall, 62% declared direct payments from the pharmaceutical industry in the last 3 years. Sixty-eight per cent felt the majority of Italian oncologists have a COI with industry, but 59% suppose this is not greater than that of other specialties. Eighty-two per cent consider that most oncology education is supported by industry. More than 75% believe that current allocation of industry budget on marketing and promotion rather than research and development is unfair, but 75% consider it appropriate to receive travel and lodging hospitality from industry. A median net profit margin of €5000 per patient enrolled in an industry trial was considered appropriate for the employee institution. Sixty per cent agree to receive a personal fee for patients enrolled in industry trials, but 79% state this should be reported in the informed consent. Over 90% believe that scientific societies should publish a financial report of industry support. Finally, 79% disagree to being a coauthor of an article written by a medical writer when no substantial scientific contribution is made. CONCLUSIONS:Among Italian oncologists COI is perceived as an important issue influencing costs, education, care and science. A more rigorous policy on COI should be implemented.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要